Gemcitabine–Pazopanib Combo Shows Antitumor Efficacy in Ovarian Cancer
April 17, 2020 11:00 amToronto, Canada—Findings from a phase 2 study prepared for presentation at the 2020 SGO Annual Meeting on Women’s Cancer showed that adding pazopanib to gemcitabine enhanced antitumor activity in patients with ovarian cancer.
“Angiogenesis inhibition is a valuable strategy for … Read more